The reproductive endocrine system of male mammals is composed of the hypothalamus of the cerebrum, ABSTRACT : The reproductive activity in male mammals is well known to be regulated by the hypothalamuspituitary-gonad axis. The hypothalamic neurons secreting gonadotropin releasing hormone (GnRH) govern the reproductive neuroendocrine system by integrating all the exogenous information impinging on themselves. The GnRH synthesized and released from the hypothalamus arrives at the anterior pituitary through the portal vessels, provoking the production of the gonadotropins(follicle-stimulating hormone (FSH) and luteinizing hormone (LH)) at the same time. The gonadotropins affect the gonads to promote spermatogenesis and to secret testosterone. Testosterone acts on the GnRH neurons by a feedback loop through the circulatory system, resulting in the balance of all the hormones by regulating reproductive activities. These hormones exert their effects by acting on their own receptors, which are included in the signal transduction pathways as well. Unexpected aberrants are arised during this course of action of each hormone. This review summarizes these abnormal phenomena, including various mutations of molecules and their actions related to the reproductive function.
The reproductive endocrine system of male mammals is composed of the hypothalamus of the cerebrum, pituitary, and gonads. The hypothalamus integrates all the information for exogenous and endogenous signals to synthesize and secret gonadotropin-releasing hormone (GnRH), regulating reproductive activities (Bliss et al., 2010) . Thus GnRH is a decisive element that is the most important and supreme position in governing reproduction. Once GnRH is released, it is transported to the anterior pituitary. The nucleus of the GnRH neuronal cell is placed in the hypothalamus of the brain, and the axonal terminals of the GnRH neuronal cells is positioned at the median eminence (ME). The hypothalamo-hypophyseal portal blood vessels are found and these vessels take the substances secreted from the axonal terminals and transfer them to the anterior pituitary. the GnRH synthesized in the cell bodies of GnRH neurons is transported via the GnRH axons and released from the ME which is the sites of the axonal terminals of the GnRH neurons. Thereafter GnRH arrives at the anterior pituitary through the portal vessels. The gonadotropes in the anterior pituitary have receptors for the GnRH in their cell membranes so that the receptors can recognize and bind to the GnRH that flowed out of the portal vessels and the binding signals are delivered to the inside of the gonadotropes. These gonadotropes produce simultaneously follicle-stimulating hormone (FSH) and luteinizing hormone (LH) according to the GnRH signals. The gonadotropins (FSH and LH) are released, moved through the systemic circulatory system, and act on the receptors of the target cells. In case of males, FSH is involved in the formation of spermatogenesis by acting on the seminiferous tubules of the gonads, and LH leads to produce testosterone that is the male sex steroid hormone, by acting on the Leydig cells that are located between the seminiferous tubules.
Testosterone also travels through the circulatory system and acts on the hypothalamus/pituitary by negative feedback to maintain the constant levels of gonadotropins all the time, possessing the active sexual functions. In D Choi Dev. Reprod. Vol. 16, No. 4 (2012) 236 case of females, FSH promotes the maturation of ovarian eggs by acting on the follicles of the ovaries, while simultaneously leading the production of the female sex steroid estrogen. LH induces ovulation to facilitate the fertilization. Overall, this reproductive endocrine system is controlled via the hypothalamus-pituitary-gonad axis.
As known from the reproductive endocrine circuit, typical and active reproductive functions are rational when This review is to define the influence of the mutation developed due to the aberration of genes on the reproductive function, in relation to the molecules that act on the hypothalamus-pituitary gonad axis. In both human beings and animals, males are a major subject to this investigation, and females are involved, if necessary.
In order to clarify the roles of the molecules more precisely, in case, genetically modified animal models are included.
Hypothalamus-Pituitary Realm
The reproductive endocrine system is activated by the GnRH released in a pulsatile fashion from the hypothalamus. The GnRH neurohormone binds to its receptor on the cell membrane of gonadotropes situated in the anterior pituitary. Then the gonadotropes synthesize and secret FSH and LH at the same time.
The aberrant molecules in this course give a vital impact on the reproductive activity.
The congenital idiopathic hypogonadotropic hypogonadism (IHH) is a disorder that is immature and incomplete symptom in spite of age of 18. People suffering from this disease show low levels of blood gonadotropins and testosterone.
The IHH appeared to be resulted by any defects in the process of synthesis, release, and action of GnRH (Huhtaniemi, 2000) . The symptom is developed with various correlations of other functions unrelated to the reproductive function, such as anosmia lacking smells, cleft palate rupturing the roofs of mouths, and sensorineural hearing losses. The IHH is classified as Kallman's syndrome when it is related to anosmia. This symptom is due to the improper movement of the GnRH neuronal cells from the olfactory epithelial cells to the hypothalamus during the development of the embryo (Franco et al., 1991; Hardelin et al., 1999) .
The more serious case is correlated to the X chromosome where the mutation directs a loss of the functioning of the KAL-1 gene encoding protein anosmin-1 (Franco et al., 1991) . When the olfactory function is working normally it is named the normosmic IHH. The genes included in the cause of IHH are numerous, such as KAL1 (Franco et al., 1991; Legouis et al., 1991) , FGFR1 (Dodé et al., 2003) , GnRH (de Roux et al., 1997; Layman et al., 1998) , NELF (Miura et al., 2004) , GPR54 (Bedecarrats et al., 2003b; Seminara et al. 2003) , FGF8, PROK2, and PROK2R (Hardelin & Dodé, 2008) . Recently, additional genes affecting the release of GnRH, containing GPR54/KISS1R, TAC3, and TACR3, are added to the list of causes of IHH (de Roux et al., 2003; Hardelin & Dodé, 2008; Semple & Topaloglu, 2010) . By working alone or in combinations of genes, the genes prevent GnRH from functioning normally. The specific treatments administering GnRH Dev. Reprod. Vol. 16, No. 4 (2012) The Consequences of Mutations in Reproductive Endocrine System 237 and gonadotropins in the pulsatile usually recover the puberty, and restore the reproductive function to its normal state. In order for the people suffering from the IHH to maintain reproductive activity and secondary sex characteristics, it has been known that hormone treatment for a lifetime is required. However, one report shows that testes can function normally even after pausing the hormone treatment after a given period of time (Raivio et al., 2007) .
The GnRH signals are not delivered intact when there is an aberrancy in the GnRH receptor anchoring on the cell membranes of gonadotropes in the anterior pituitary, even though GnRH is produced and released under normal conditions. In addition, it is also important that gonadotropes produce FSH and LH accurately.
Defects of GnRH
GnRH is secreted from the hypothalamus in a fashion of pulse (Belchetz et al., 1978; Marshall & Kelch, 1986; Tsutsumi & Webster, 2009) . Although exogenous GnRH is administered continuously into animals whose hypothalami containing GnRH neurons are surgically destroyed, the IHH is not cured without the increase of gonadotropins.
Yet the pulsatile administration of GnRH in an interval of one hour showed normal spermatogenesis as a result of recovery of gonadal functioning (Belchetz et al., 1978) .
This emphasizes the critical actions of the pulsatile GnRH.
The GnRH is not produced from an animal that has a deletion mutation of the gene producing GnRH, If any GnRH produced, leading to IHH by the lack of function (Mason et al., 1986a) . This mouse does not undergo puberty, and hypogonadotropic hypogonadism (HH)
continues, but the phenomenon might be recovered by proper administration of GnRH (Mason et al., 1986b) .
In case of the surgical amputation between the connection of the hypothalamus and the pituitary, IHH is induced secondarily by an abrupt decrease of gonadotropins (Clarke et al., 1983; Clarke & Cimmins, 1984) .
There is a report of insertion mutation where an adenine is added between adenine 18 and cytosine 19 of a gene generating GnRH (18insA); the latter is followed by the former (Bouligand et al., 2009 
Defects of GnRH receptors
The GnRH receptor (GnRHR) is a member of G protein-coupled receptor family and consists of 324 amino acids. This receptor is primarily expressed in the gonadotropes and even in the breast, gonads, prostate, and uterus in animals, including human beings (Cheung & Wong, 2008) . GnRH receptor mutations occurr naturally and induce IHH (de Roux et al., 1997; Beranova et al., 2001; Bedecarrats et al., 2003a Bedecarrats et al., , 2003b Wolczynski et al., 2003; Bedecarrats & Kaiser, 2007; Fichna et al., 2011) . There are several sites in the GnRH receptor gene where mutations happen. A mutation was reported that the amino acid 139 arginine in GnRHR was replaced by histidine (Arg139His) due to the alteration of guanine to adenine in position 416 of exon 1 of the GnRHR gene (Fichna et al., 2011) . The mutation occurred in that place of the GnRHR gene was discovered before (Costa et al., 2001; Wołczynski et al., 2003; Topaloglu et al., 2006 Thr32Ile, Cys200Tyr, Leu266Arg, and Cys279Tyr, in the order of the amino acids of the GnRH receptor (Beranova et al., 2001; Bedecarrats et al., 2003a) 
Pituitary-Gonad Realm
Gonadotropins are FSH and LH released from the anterior pituitary and belong to the glycoprotein family.
They are consisted of two subunits, having an α subunit in common, and a unique β subunit. This αβ dimer contains some carbohydrates. (Themmen & Huhtaniemi, 2000) .
This loss of function mutation of FSHR makes the small testes, which are not typical in males, and reduces estrogen production without matured follicles.
The continuously activated FSHR makes testes large by increasing the Sertoli cells within the gonads (Simoni et al., 1997; Simoni et al., 1999) . In females with the same phenomenon, the follicular cells grow excessively, cause the ovarian tumor, increase the incidence of fraternal twins, and undergo premature menopause (Ligtenberg et al., 1999) . If the LHR holds its continuously activated situation, it ultimately provokes the same results as the process that the gonadotropins act, by being capable of transducing signals even in the absence of the LH hormone signals. The perfect inactivating mutations show the adverse effects and vanish or diminish the actions of the hormones. Also, by different Dev. Reprod. Vol. 16, No. 4 (2012) The Consequences of Mutations in Reproductive Endocrine System 239 quantitative effects of the hormones, the influence of the hormones can be emerged partially or not at all.
Defects of α subunit common to gonadotropins
A mutation was reported in a human being where glutamine 56 was replaced by alanine (Glu56Ala) in α subunit common to the gonadotropins (Nishimura et al., 1986) .
This mutated protein is significantly bigger than the normal protein that it is not possible to cooperate to β subunit to form a dimer. Thus there is no sound stereostructure, no formation of a dimer, and no configuration of the glycosylation in this mutant. This mutant affects the gonadotropins, thyroid stimulating hormone, and even human chorionic gonadotropins. It does not form intact germ cells so that the individual turns out infertility.
FSHβ and defects of FSH receptors
There is a report that observes the complete inactivation of the mutant occurred in the FSHβ subunit gene in both males and females (Berger et al., 2005) . In males, puberty arrived normally but FSH was not detected at the level of the standard. The mutant showed a male with azoospermia while the LH and testosterone levels were acting normally (Lindstedt et al., 1998) . In females, there were the infertile state, the primary amenorhhea, and the absence of telarche.
The alteration of thymine to cytosine in a nucleotide of the FSHβ gene guides the protein to mutate with were reported. The woman with this mutation showed high levels of FSH and LH, but she suffered from the lack of secondary characteristics and the disorder of ovarian developments (Aittomäki et al., 1996) . It is The other FSHR mutation is Asp224Val, which almost does not bind to FSH (exon 3, the third intracellular loop), and Leu601Val mutation (exon 10, the third intracellular loop) showed about 15% of the signal transduction function. Mutations that FSHR works somewhat less than the standard were also found, presenting the secondary amenorrhea and absence or weakening of the secondary follicle development (Beau et al 1998) . These mutations are Ile160Thr (exon 6, extracellular domain) and Arg573Cys (exon 10, the third intracellular loop, resulting in abnormal expression on the cell membrane and deviant binding to the G protein.
The constantly activating FSHR mutation was also reported (Gromoll et al., 1996) . When testosterone was administered to a male who took surgically out pituitary, the levels of gonadotropins were very low, but the spermatogenesis functioned as standard. This mutation is Asp567Gly (exon 10, the third intracellular loop), Asp564Gly mutation in LHR is always activated and exerts its effects.
LHβ and defects of LH receptors
A male who had mutation in the LHβ gene did not undergo puberty normally even at the age of 17 (Weiss et al., 1992) . Although the levels of testosterone in blood were low, the man responded normally to the administration of hCG. The blood levels of LH detected from this man had no biological activity. The man had 3 persons who were sterile among his relatives, thus it was regarded that he might have innate defects in the structure of LH. It turned out that he had a missense mutant altered from glutamine to arginine by anomaly changing adenine to guanine in the LHβ gene 54. His mother, sister, and maternal uncle were identified as heterozygote in the same site of the LHβ gene. When this LHβ gene mutant was expressed with a normal α subunit gene of the gonadotropin simultaneously in CHO (Chinese hamster ovary) cells, it was speculated that the LH αβ dimers were formed, but could not bind to LH receptors by the absence of activation.
A mutation was found in a protein where three amino acids (amino acid 10 to 12; histone-proline-isoleucine) were lacked by deletion of nine nucleotides in exon 2 of the LHβ gene (Achard et al., 2009 ). This man did not show muscularizing effects, the concentration of LH was not detected, and the blood testosterone levels were low. Also, there were not many Leydig cells between the seminiferous tubules of the testis. Yet, he had intact spermatozoa, thus the process of spermatogenesis was thought unimpaired. It was concluded that the LHβ mutant protein was enough to proceed Dev. Reprod. Vol. 16, No. 4 (2012) The Consequences of Mutations in Reproductive Endocrine System 241 normal functions in the spermatogenesis because it showed some feasible functions in the in vitro experiment. One of this man's sisters presented identical symptoms of the mutation. That is, when the sister was 14 years old, she underwent menarche, oligomenorrhea, and secondary amenorrhea. When she grew-up, she demonstrated macrocysts in both ovaries. The levels of LH could not be detected, estradiol concentration was low, but FSH was elevated.
A mutation was reported where 2 sites in the LHβ gene were altered (Arnhold et al., 2009 ). It was a mutant of both Trp8Arg (TGG CGG) and Ile15Thr → (ATC ACC), → occurring in the order of amino acids (Pettersson et al., 1994; Nilsson et al., 1998) . The infertile women with the same mutation were successively recorded, in which the concentration of LH was not detected (Furui et al., 1994; Okuda et al., 1994) .
Many mutations were emerged from the LHR gene, such as polymorphism without any functional changes, persistent activation, and chronic inactivation (Laue et al., 1995; Martens et al., 1998; Auger et al., 2008; Themmen & Huhtaniemi, 2000) . As soon as LHR is by a factor of 5-15 without respect to LH (Shenker et al., 1993; Kraaij et al., 1995; Liu et al., 1999) .
The mutation of LHR with chronic inactivation is pseudohermaphroditism, where the sex chromosomes turned out XY, but the affected person had female exterior genital organs (Themmen & Huhtaniemi, 2000) . The In females, the inactivation of LHR appeared to be anovulatory amenorrhea, primary and secondary sex characteristics developed normally, but the levels of FSH and LH were elevated, the concentrations of estrogen and progesterone were diminished. When the ovaries were analyzed by histological examinations, the follicles stayed at an immature phase, had no corpus luteum in ovaries, and showed no ovulation. (La Spada et al., 1991; Griffin, 1992; Quigley et al., 1995; McPhaul, 1999) . The affected person showed a variety of symptoms from the feminization of genital organs and the absence of puberty to meager disorders (some fertiles), while similar symptoms were reported in animals such as mice and rats (Bardin et al., 1970; Lyon & Hawkes, 1970; Goldstein & Wilson, 1972; Giwercman et al., 2000; Chu et al., 2002) . Another mutation was recorded where 840 amino acid arginine was changed to cysteine by the replacement of cytocine to thymine at 375 nucleotide in exon 7 of the AR gene.
Androgen and Defects of Androgen Receptors and Others
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Dev. Reprod. Vol. 16, No. 4 (2012) 242 Family members who show these kinds of symptoms were mostly sterile, and some had the capability of pregnancy despite having the same characteristics. These consequences mean that there is another mechanism that is able to overcome this mutation. The Sertoli cells within the seminiferous tubule and the Leydig cells, functioning an important role in testis, present AR (Sar et al., 1990; Bremner et al., 1994; Vornberger et al., 1994) . The knockout (loss of function of gene) male rats that lack the function of AR demonstrated very similar symptoms as seen in AIS and Tfm (Yeh et al., 2002; Matsumoto et al., 2003) . The levels of gonadotropins in a man who had a mutant in AR were high and testosterone was normal. The person had a mutation in exon 1 of the AR gene, thus 240 amino acid alanine was replaced by serine (Ala240Ser), resulting in sterile (Goglia et al., 2011) .
A mutation (Asn727Lys) occurring in the AR-ligand binding domain impairs the spermatogenesis seriously, leading to infertile (Yong et al., 1994) . In this case, cytocine was replaced by guanine, guiding the alteration of asparagine to lysine at the 727 amino acid in AR (Lim et al., 2000) . The mutated site was located between the third and the fourth of ligand-binding domains, if treated with androgen analog mesterolone (1α-methyl-DHT, 1α-methyl-17βhydroxy-5α-androstan-3-one), pregnancy could be performed by producing normal spermatozoa.
When the treatment of mesterolone stops, the production of spermatozoa is lacked, thus the AR mutations are known to be regulated by administrations of the proper drugs.
The sterile individual was emerged by impairment of spermatogenesis, in case that substituted methionine with valine, due to a mutation of altering adenine to guanine in 886 nucleotide in exon 8 of the AR gene. This substitution resulted in the AR-ligand binding domain as usual, the binding was not an aberrant binding, thus it was speculated that an unusual process was emerged in the signal transduction pathway which is aided by the assistant factors (Ghadessy et al., 1999) . More results similar to the consequences mentioned above were already recorded (Yong et al., 1994; Berrevoets et al., 1998; Wang et al., 1998) . The administration of androgen to a mouse who did not produce gonadotropins normalized the spermatogenesis, but the FSH treatment did not recover the spermatogenesis perfectly (Singh & Handelsman, 1996; Haywood et al., 2003) . Thus, in order for the androgen and its receptor to generate mature spermatozoa, A mouse that does not express kisspeptin or its receptors presents HH and becomes infertile. When the kisspeptin is exogenously administered to a mouse without expression of kisspeptin, spermatogenesis is recovered partly. Yet, the mouse who does not express kisspeptin receptors does not respond to the treatment of kisspeptin (Berger et al., 2005) . The mouse who does not express the estrogen receptor α becomes sterile, and does not respond to estrogen as well. While the mouse who does not express ER β showed an impairment in the capacity of ovulation, but the mouse does respond to exogenous estrogen (Wintermantel et al., 2006) . Besides the results inscribed above, there are a great deal of mutations inducing sterility (Romero et al., 2011) .
Transgenic Animals
Many experiments apply the alteration of a particular part of a gene to produce functional modifications.
There were reports that mutations were occurred in the α subunit common to genadotropins and in the unique Dev. Reprod. Vol. 16, No. 4 (2012) The Consequences of Mutations in Reproductive Endocrine System 243
FSHβ subunit in mice (Kendall et al., 1994; Kumar et al., 1997) . As expected, mutations that vanished the function of the α subunit gene appeared as a dwarf due to the IHH and the hypothyroidism. The thyroid underdeveloped at the later period of pregnancy in the mouse, and the development of gonads was inhibited several weeks after birth. However, steps involved in the movement of the GnRH neuronal cells, the development of organs related to sex, and the gonadal growth appeared to be normal.
Although the small testes and the impaired spermatogenesis were observed in the knockout male mouse whose FSH β gene was inactivated, the mouse became muscularized and fertile (Kumar et al., 1997) . This mutation was quite similar to the FSHR knockout male mouse and men with persistently inactivated mutations (Tapanainen et al., 1997; Dierich et al., 1998; Abel et al., 2000) . In results, FSH is required for the normal size of gonads and the qualitative aspects of typical spermatogenesis, but has less importance for the spermatogenesis itself and reproductive functioning of males.
The FSHβ knockout female mouse is infertile because the formation of follicles is paused before the growth of the secondary follicles (Kumar et al., 1997) . This incidence is analogous to the mutations occurred in the FSHβ and FSHR of human beings (Aittomaki et al., 1995) . The FSHR knockout results in mice are considerably similar as well (Dierich et al., 1998; Abel et al., 2000) . All the females are sterile, the ovaries are small and attenuated, the corpus lutea are absent, and even the oogenesis presents not to proceed until the secondary follicular maturation.
The transgenic male mouse with overexpression of FSH exhibited normal differentiation of gonads and spermatozoa formation (Kumar et al., 1999 ). Yet, the mouse was sterile because of the potential abnormal behavior, defective spermatozoa, or imperfect semen. The levels of testosterone were high, and seminal vesicles were enlarged in the mouse. The elevated FSH concentration seemed to somehow stimulate the Leydig cells. A man whose pituitary adenoma secreted a large amount of FSH showed abnormal testicles (Galway et al., 1990) .
The female mouse overexpressed FSH was sterile, the mouse presented cystic ovary, and the levels of blood testosterone, estradiol, and progesterone were increased (Kumar et al., 1999) . It was found that FSH alone does not induce tumor because no ovarian tumors were discovered. Thus it is speculated that the sterile situation was caused by anomalous oogenesis and the formation of ovarian cysts.
If the LHβ subunit gene or the LH receptor gene is removed from the mouse, the sterile state is induced in both sexes, steroid hormone is produced less in testicles of males, release of the hormone is also diminished, thus spermatogenesis in males is defected and the follicular maturation in females is paused (Lei et al., 2001; Zhang et al., 2001) . The defects of the FSH receptor in males seriously impair the testicular function and lead to the reduction of numbers of the Leydig cells and the decrease of testosterone (Baker et al., 2003) . As the concentration of FSH is normal in the animal, the exogenous LH can overcome IHH in the absence of the LHβ subunit (Kumar et al., 1997) . Similarly, a female mouse also becomes infertile by pausing the follicular maturation if defects exist in the FSH receptor (Dierich et al., 1998; Abel et al., 2000) . The levels of LH appeared to be not high in the male mouse overexpressed LH, but the LH levels were elevated in the female overexpressed LH (Risma et al., 1995) . This female was sterile with almost no ovulation, showed a delayed period of the corpus luteum, and developed swollen cysts and pathological ovarian diseases like tumor in the granulosa cells and the theca interna cells. Moreover, the adrenal glands were abnormal in some animals.
Therefore, the persistently high levels of LH correlate to ovarian tumor, and to some degrees, the polycystic ovary syndrome (PCOS) in humans as well. As mentioned above, the action of the gonadotropin has been found D Choi Dev. Reprod. Vol. 16, No. 4 (2012) 244 in a knockout model of the α and FSHβ subunits.
Experimental results that the function of the FSHR gene was altered were reported (Dierich et al., 1998; Abel et al., 2000) . The mouse whose LHβ subunit is not expressed survives, but becomes sterile since the loss of the gonadal growth. The testicles in these mice are small, the Leydig cells are not differentiated, and the blood testosterone levels were low. The spermatogenesis of the mice does not proceed to elongated spermatids by ceasing the stage of round spermatid. There are small ovaries in females and decreased levels of estradiol and progesterone in blood. The oogenesis is not normal, the follicles are not matured, thus the corpus lutea are not observed at all. The abnormal symptoms were recovered when the mouse was administered by sufficient hCG that is similar to LH in the structural aspect, so the responsiveness of the LH target cells appeared to be normal. Thus it would be a good model to investigate the effects of the absence of LH, provided that the responsiveness of LH in the target cells is ordinary in the knockout animal where the LHβ gene is not expressed (Kumar, 2007; Ma et al., 2004) .
The male mouse with the loss of function of FSHR is fertile, has small testes, and shows low concentration of testosterone. The number of quite active spermatozoa is small and the portions of abnormal spermatozoa are increased. The decrease of testis in size is due to the reduction of the volume of the seminiferous tubule. The pituitary was enlarged by the increase of FSH concentrations 2-3 times and the number of the cells producing FSH was increased. In many aspects, the mouse whose function of FSH is deficient showed a similar phenomenon in the inactivated person by the mutation occurred on the activity of FSHR (Aittomäki et al., 1995 (Aittomäki et al., , 1996 Tapanainen et al., 1997) . In other words, the number of abnormal spermatozoa is great but the spermatogenesis was not arrested completely, and the follicular development in females was inhibited whereas the primary follicles remained intact. The female mouse with the loss of function of FSHR by replacing exon 1 of FSHR with a marker gene was found sterile, had high levels of FSH concentration, had the small ovaries, had the low levels of estrogen, the inhibited follicular development and thin womb, and exhibited no matured follicle and no corpus lutea (Dierich et al., 1998) . The mutants discovered in the FSHR of women are Asn680Ser, Ala189Val, Ile160Thr, and Thr449Ile (Binder et al., 2012 (Liu et al., 1999) . Also, uniformly high concentrations of gonadotropins can cause tumor development in organs such as the adrenal glands by leading to express the gonadotropin receptors in other places than gonads. Yet, it has not been satisfactorily Dev. Reprod. Vol. 16, No. 4 (2012) The Consequences of Mutations in Reproductive Endocrine System 245 explained how the gonadotropin receptors are expressed in other tissues, except for the gonads (Rao, 1996) .
The knockout mouse of LHR would be helpful in solving this problem, and the animal models would be useful in studying the mutants of mRNA of gonadotropin receptors.
As the roles of the normal and abnormal gonadotropins are understood, new discoveries in the regulatory mechanism of the reproductive endocrine system are accomplished and announced. Not only the genetically modified animal models, but also the gonadotropins of human beings and the mutations and polymorphism of their genes will reveal fundamentally the action mechanism of reproductive endocrine system through the novel information in the area of the hormonal control regarding the reproductive functioning.
